|
|
|
|||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Markus
Büchler, MD Ralph
Hruban, MD Eileen
O'Reilly, MD Margaret
Tempero, MD ![]() Please join us in Denver Pam Saunders Charity Gala November 15, 2008 ![]() Support Taylor's project
![]() More Information In Remembrance |
Frequently Asked Questions on Pancreatic Cancer Answers to questions about pancreatic cancer: covers such areas as definitions, pancreatic cancer stages, symptoms, diagnosis, prognosis, medical treatment, the Whipple procedure surgery, support and other related issues Pancreatic
Cancer Clinical Trials Database Pancreatic
Cancer Medical Literature Select
Abstracts sm
in Pancreatic Cancer
|
|||||||||||||||||||||||||||||||||||||||
|
|
||
|
||
|
Aetna Park To Park 10 Miler Denver, Colorado 10/5/08 Army 10 Miler Washington, D.C. (Baltimore, Maryland runners encouraged!) 11/9/08 Big Sur Half Marathon Monterey, California |
Banco Popular Chicago Half Marathon Chicago, Illinois 11/2/08 US Half Marathon San Francisco, California 11/27/08 Atlanta Half Marathon Atlanta, Georgia |
|
|
Chevron Houston Half Marathon Houston, Texas |
||
|
|
||
For more information and online registration click here
You can call Toll Free 877-647-0400
or click on a race above to learn more
|
Pancreatica Running
Team |
runners@pancreatica.org |
|
|
CAPS 3 Study for those at High Risk for Pancreatic Cancer
|
Survivor
Stories
Read these stories
of long-term pancreatic cancer survivors by clicking here
![]() |
|
|
Pancreatic
Cancer Registries
In this age of molecular
biology and armed with new understandings about the role that
genes play in pancreatic cancer, familial registries are increasingly
a powerful resource to help gain a better understanding of the
disease - and hence better detection or treatment possibilities.
There are about fifteen cancer
registries worldwide that are specific to cancer of the pancreas
For more information please click here
Select
Abstracts
(most
recent)
For
access to all abstracts back to 2003, please click here
Borderline Resectable Pancreatic
Cancer: The Importance of this Emerging Stage of Disease.
Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey
JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF.
J Am Coll Surg. 2008 May;206(5):833-46; discussion 846-8. The
University of Texas / MD Anderson Cancer Center, Houston.
[Link
to Abstract]
Prospective Phase II Trial
of Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin for
Resectable Adenocarcinoma of the Pancreatic Head.
Heinrich S, Pestalozzi
BC, Scha"fer M, Weber A, Bauerfeind P, Knuth A, Clavien
PA.
J Clin Oncol. 2008 May 20;26(15):2526-31. Institute of Surgical
Pathology, Swiss Hepato-Pancreato-Biliary Center, Zurich.
[Link
to Abstract]
Response to a Third-Line Mitomycin C (MMC)-Based Chemotherapy
in a Patient with Metastatic Pancreatic Adenocarcinoma Carrying
Germline BRCA2 Mutation.
Chalasani P, Kurtin S, Dragovich T.
JOP. 2008 May 8;9(3):305-8. Arizona Cancer Center, University
Medical Center, Tucson.
[Link
to Abstract]
Surgery and Radiofrequency
Ablation for Treatment of Liver Metastases from Midgut and Foregut
Carcinoids and Endocrine Pancreatic Tumors.
Eriksson J, Sta*lberg
P, Nilsson A, Krause J, Lundberg C, Skogseid B, Granberg D, Eriksson
B, Akerstro"m G, Hellman P.
World J Surg. 2008 May;32(5):930-8. University Hospital, Uppsala,
Sweden.
[Link
to Abstract]
Cancer is the second most common cause of death in the developed world, behind cardiovascular disease. Pancreatic cancer is the fourth most common cause of cancer mortality (behind lung cancer, colorectal cancer and breast cancer).
250 people in North America and Europe will die today from pancreatic cancer. (90,000 deaths per year).
The U.S. National Cancer Institute funds pancreatic cancer research at shockingly low levels (year 2005-07 figures). Pancreatic cancer research receives (per mortality):
15%
of the funding of breast cancer (but causes 82% of the mortality)
17% of the funding of prostate
cancer (but causes more mortality)
41% of the funding of colorectal
cancer (but causes 63% of the mortality)
Supporters of Our Effort Against Pancreatic
Cancer
Compassionate generosity from the philanthropic and business
world
How
Are We Doing?
Please give us feedback
|
We comply with the HONcode standard for health trust worthy
information: verify here. |